See more : Knorr-Bremse Aktiengesellschaft (0KBI.L) Income Statement Analysis – Financial Results
Complete financial analysis of Bright Health Group, Inc. (BHG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bright Health Group, Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
You may be interested
- Eurotech S.p.A. (ERTWF) Income Statement Analysis – Financial Results
- Kilburn Engineering Limited (KLBRENG-B.BO) Income Statement Analysis – Financial Results
- DRB-HICOM Berhad (1619.KL) Income Statement Analysis – Financial Results
- Energy Transfer LP (ET-PI) Income Statement Analysis – Financial Results
- Logility Supply Chain Solutions, Inc. (LGTY) Income Statement Analysis – Financial Results
Bright Health Group, Inc. (BHG)
About Bright Health Group, Inc.
Bright Health Group, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, NeueHealth and Bright HealthCare. The NeueHealth segment delivers virtual and in-person clinical care services to patients under contracts through its owned and affiliated primary care clinics. As of December 31, 2021, it worked with approximately 260,000 care provider partners; and operated 180 managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers commercial and medicare health plan products to consumers in 14 states and 99 markets. The company was formerly known as Bright Health Inc. and changed its name to Bright Health Group, Inc. in February 2021. Bright Health Group, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.16B | 2.41B | 4.03B | 1.21B | 280.67M | 130.63M |
| Cost of Revenue | 1.28B | 2.21B | 3.95B | 1.05B | 224.39M | 96.41M |
| Gross Profit | -122.92M | 205.79M | 75.72M | 160.02M | 56.29M | 34.23M |
| Gross Profit Ratio | -10.59% | 8.53% | 1.88% | 13.25% | 20.05% | 26.20% |
| Research & Development | 0.00 | 0.00 | 0.00 | 19.43M | 7.24M | 2.54M |
| General & Administrative | 0.00 | 501.84M | 626.36M | 211.75M | 104.22M | 54.48M |
| Selling & Marketing | 0.00 | 82.34M | 287.76M | 96.94M | 49.71M | 26.75M |
| SG&A | 0.00 | 584.18M | 914.11M | 308.69M | 153.93M | 81.23M |
| Other Expenses | 1.74B | 98.28M | 359.76M | 89.50M | 20.45M | 13.09M |
| Operating Expenses | 1.74B | 682.46M | 1.27B | 417.62M | 181.62M | 96.87M |
| Cost & Expenses | 3.02B | 2.89B | 5.23B | 1.46B | 406.01M | 193.27M |
| Interest Income | 0.00 | 12.82M | 7.23M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 38.20M | 12.82M | 7.96M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 24.17M | 51.36M | 36.71M | 8.29M | 1.13M | 1.03M |
| EBITDA | -1.15B | -425.31M | -1.16B | -249.31M | -124.20M | -61.61M |
| EBITDA Ratio | -98.68% | -17.63% | -28.82% | -20.65% | -44.25% | -47.16% |
| Operating Income | -627.74M | -476.67M | -1.20B | -257.60M | -125.34M | -62.64M |
| Operating Income Ratio | -54.08% | -19.76% | -29.74% | -21.34% | -44.66% | -47.95% |
| Total Other Income/Expenses | -1.43M | -157.61M | -861.96M | -3.80M | 0.00 | 0.00 |
| Income Before Tax | -629.17M | -634.29M | -1.20B | -257.60M | -125.34M | -62.64M |
| Income Before Tax Ratio | -54.20% | -26.30% | -29.90% | -21.34% | -44.66% | -47.95% |
| Income Tax Expense | -1.43M | 3.68M | -26.52M | -9.16M | 8.35M | 3.51M |
| Net Income | -1.20B | -637.97M | -1.18B | -248.44M | -133.69M | -62.64M |
| Net Income Ratio | -103.43% | -26.45% | -29.24% | -20.58% | -47.63% | -47.95% |
| EPS | -150.94 | -81.08 | -240.33 | -145.94 | -79.52 | -37.97 |
| EPS Diluted | -150.94 | -81.08 | -240.33 | -145.94 | -79.52 | -37.97 |
| Weighted Avg Shares Out | 7.95M | 7.87M | 4.90M | 1.70M | 1.68M | 1.65M |
| Weighted Avg Shares Out (Dil) | 7.95M | 7.87M | 4.90M | 1.70M | 1.68M | 1.65M |
Bright Health Group, Inc. (BHG) Q1 2023 Earnings Call Transcript
Bright Health Group, Inc. (NYSE:BHG ) Q1 2023 Earnings Conference Call May 9, 2023 8:00 AM ET Company Participants Stephen Hagan - Investor Relations Director Mike Mikan - President and CEO Cathy Smith - Chief Administrative Officer and CFO Conference...
Buxton Helmsley Issues Letter to Mallinckrodt Plc. Regarding Continued Evidentially False Statements of Financials
NEW YORK--(BUSINESS WIRE)--The Buxton Helmsley Group, Inc. (together with certain of its affiliates, “BHG” or “we”), the New York City-based investment advisor to clients with financial interests in Mallinckrodt Plc. (“Mallinckrodt” or the “Company”) (NYSE: MNK), today issued an open...
Bright Health Group Reports First Quarter 2023 Results
MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial results for its first quarter ended March 31, 2023. “Bright...
Bright Health Group Appoints Jay Matushak as Chief Financial Officer
MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced that it has appointed Jay Matushak as the Company’s next Chief...
Bright Health Group to Explore Strategic Alternatives for Medicare Advantage Business as it Focuses on Driving Performance through its Consumer Care Delivery Business
MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG), today announced that it is exploring strategic alternatives for its California Medicare Advantage business, which consists of Brand New Day and Central Health Plan, with a focus on...
Buxton Helmsley Issues Letter to Mallinckrodt Plc. Regarding Failure to Address Evidential Multibillion-Dollar Asset Value Depreciation Expense Concealment Scheme
NEW YORK--(BUSINESS WIRE)--The Buxton Helmsley Group, Inc. (together with certain of its affiliates, “BHG” or “we”), the New York City-based investment advisor to clients with financial interests in Mallinckrodt Plc. (“Mallinckrodt” or the “Company”) (NYSE: MNK), today issued an open...
Bright Health Group to Host First Quarter 2023 Earnings Conference Call on May 9, 2023
MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report First Quarter financial results before the financial markets open on Tuesday,...
Bright Health Group to Host First Quarter 2023 Earnings Conference Call on May 9, 2023
MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report First Quarter financial results before the financial markets open on Tuesday,...
Pinnacle Financial Partners Announces 1Q23 Dividend
NASHVILLE, Tenn.--(BUSINESS WIRE)--Pinnacle Financial Partners, Inc. (Nasdaq/NGS: PNFP) announced today that its Board of Directors has approved a $0.22 per share cash dividend to be paid on May 26, 2023 to common shareholders of record as of the close of...
PNFP Reports Diluted EPS of $1.76, ROAA of 1.26% and ROATCE of 15.43% For 1Q23
NASHVILLE, Tenn.--(BUSINESS WIRE)--Pinnacle Financial Partners, Inc. (Nasdaq/NGS: PNFP) reported net income per diluted common share of $1.76 for the quarter ended March 31, 2023, compared to net income per diluted common share of $1.65 for the quarter ended March 31,...
Source: https://incomestatements.info
Category: Stock Reports